Proprioceptive Network Dysfunction in Functional Movement Disorders: Mechanisms, Clinical Implications, and Management

Abstract

Proprioceptive network dysfunction has emerged as a central component in the pathophysiology of functional movement disorders (FMD), a group of conditions historically termed psychogenic or conversion disorders. This review synthesizes recent evidence elucidating the disrupted integration of proprioceptive input within sensorimotor networks, its epidemiological and clinical implications, and the evolving therapeutic landscape. Emphasis is placed on mechanistic insights, risk factors, diagnostic approaches, and guideline-based management, aiming to enhance understanding among clinicians and inform evidence-driven practice in this challenging neuropsychiatric domain.

Introduction

Functional movement disorders (FMD) are characterized by abnormal involuntary movements, postures, or gait disturbances that are incongruent with known neurological diseases. Traditionally considered under the umbrella of conversion disorders, FMD represents a spectrum of motor symptoms with a basis in altered brain network functioning rather than structural pathology. Increasing evidence implicates proprioceptive network dysfunction—disruption in the integration and processing of sensory feedback from muscles and joints—as a core mechanism. Understanding the role of proprioceptive disturbances in FMD is critical for accurate diagnosis, patient education, and the development of targeted treatments.

Epidemiology / Disease Burden

FMD accounts for approximately 16% of new outpatient movement disorder clinic referrals, making it one of the most common causes of movement disorder after Parkinson’s disease. The prevalence is estimated at 50-100 per 100,000 individuals, with a higher incidence in women and peak onset between ages 35 and 50. FMD imposes a significant burden on patients, health systems, and society through disability, healthcare utilization, and associated psychiatric comorbidities such as depression and anxiety. Diagnostic delays are common, often exceeding five years from symptom onset, underscoring the need for improved recognition and management strategies.

Pathophysiology

Recent research incorporating functional MRI, EEG, and transcranial magnetic stimulation has clarified that FMD is not a diagnosis of exclusion but is rooted in dysfunction of brain networks responsible for movement control and self-agency. Central to this is the proprioceptive network, encompassing peripheral receptors, spinal pathways, thalamic relays, and cortical areas such as the primary somatosensory cortex, supplementary motor area, and parietal association cortex. In FMD, there is impaired integration of proprioceptive input, leading to deficient sensorimotor predictions and abnormal sense of agency. Aberrant connectivity between the prefrontal cortex, limbic system, and sensorimotor networks further contributes to symptom generation and perpetuation. These findings suggest that FMD is a disorder of network function, not malingering or feigning.

Risk Factors

Several risk factors predispose individuals to FMD, including female sex, psychological stressors, maladaptive personality traits, and a history of trauma or psychiatric illness. Neurobiological predispositions, such as heightened interoceptive sensitivity and abnormal attentional focus on bodily sensations, may interact with environmental triggers to disrupt proprioceptive integration. Additionally, prior physical injury or neurological illness can act as a precipitating factor, possibly by sensitizing sensorimotor circuits to aberrant feedback. Recognition of these risk factors allows clinicians to take a holistic approach to patient assessment and management.

Clinical Features

FMD presents with a wide array of motor symptoms, including tremor, dystonia, myoclonus, gait disturbances, and abnormal postures. Clinical hallmarks include variability, distractibility, and incongruence with organic movement disorders. Proprioceptive deficits may manifest as impaired joint position sense, abnormal limb localization, and inconsistent performance on tasks involving sensory feedback. Symptoms often fluctuate with attention or emotional state, and patients may demonstrate "entrainment"—synchronization of abnormal movements with external rhythmic cues. A thorough clinical examination, including bedside tests of proprioception and motor function under distraction, is essential for diagnosis.

Diagnosis

Diagnosis of FMD is based on positive clinical criteria rather than exclusion. Key diagnostic features include inconsistency, incongruence, and distractibility of symptoms. Ancillary testing—such as electrophysiological studies, neuroimaging, and proprioceptive assessments—can help exclude structural or neurodegenerative etiologies and support the diagnosis. Functional imaging studies may reveal abnormal connectivity in sensorimotor networks, but these are primarily research tools. Early and clear communication of the diagnosis is critical to avoid unnecessary investigations and to facilitate patient engagement in treatment.

Treatment & Management

Management of FMD is multidisciplinary and centers on patient education, physiotherapy, and psychological interventions. Education should emphasize the involuntary nature of symptoms and the role of brain network dysfunction. Specialist neurophysiotherapy aims to retrain normal movement patterns by reinforcing accurate proprioceptive feedback and minimizing maladaptive attentional focus. Cognitive-behavioral therapy and other psychotherapeutic modalities address underlying psychological stressors and maladaptive coping strategies. Pharmacological treatment is not indicated for the motor symptoms themselves but may target comorbid mood or anxiety disorders. Early intervention and engagement of a coordinated care team are associated with better outcomes.

Recent Advances / Emerging Therapies

Emerging therapies target proprioceptive network dysfunction more directly. Techniques such as sensorimotor retraining, mirror therapy, and graded motor imagery have shown promise in small clinical trials. Non-invasive brain stimulation, including repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), is being investigated for its potential to modulate abnormal network activity. Digital health technologies, including virtual reality and wearable biofeedback devices, offer novel avenues for guided proprioceptive rehabilitation. Ongoing research aims to refine patient selection and optimize protocols for these interventions.

Guideline Recommendations

Current guidelines, including those from the International Parkinson and Movement Disorder Society, recommend a diagnosis based on positive clinical features, early multidisciplinary intervention, and avoidance of unnecessary investigations. Physiotherapy focused on retraining movement and proprioception is central, complemented by psychological support where indicated. Guidelines emphasize the importance of clear communication, validation of the patient’s experience, and regular follow-up to monitor progress and address relapses. There is a consensus that treatment should be individualized based on clinical features, comorbidities, and patient preferences.

Conclusion

Proprioceptive network dysfunction represents a mechanistic cornerstone in the pathogenesis of functional movement disorders. Advances in neuroimaging and neurophysiology have shifted the paradigm from a diagnosis of exclusion to one grounded in positive clinical and mechanistic criteria. Recognition of the role of proprioceptive integration, coupled with evidence-based multidisciplinary management, has improved patient outcomes and reduced stigma. Future research should continue to elucidate the neurobiological underpinnings and refine targeted therapies, fostering a more nuanced and effective approach to this complex group of disorders.